Influenza A H1N1: Retrospective Analysis of PCR Confirmed Cases of H1N1 Infections in Styria - Risk Factors, Clinical Features and Outcome.
NCT ID: NCT01343979
Last Updated: 2015-04-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
800 participants
OBSERVATIONAL
2010-10-31
2015-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Health Status Prior and Post Infection With Influenza or COVID 19: a Population Based Retrospective Analysis of 2016-2021
NCT05087355
Retrospective Evaluation of Clinical, Virological and Serological Data in Patients With Mild Acute Upper Respiratory Tract Infections
NCT05134766
Nasal Specimen Collection Study in Patients With ILI and/or ARI in an Outpatient Setting
NCT01687816
Surveillance of Influenza in Paediatric Intensive Care Units in Bavaria
NCT01286285
Hospital Stay and Respiratory Infection
NCT02047383
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
positive
Patients with clinically suspected H1N1 infection confirmed by positive H1N1 PCR
No interventions assigned to this group
negative
Patients with clinically suspected H1N1 infection and negative H1N1 PCR
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Stratification according to the following definition:
* PCR-negative influenza-like illness (ILI) is defined as febrile illness tested by PCR for the presence of influenza infection but finally not proved as influenza infection.
* Influenza illness is defined as febrile illness confirmed by positive PCR as true influenza infection.
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Graz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Robert Krause, MD
ao.Univ.Prof.Dr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Martin Hoenigl, MD
Role: PRINCIPAL_INVESTIGATOR
Medical University of Graz
Robert Krause, MD
Role: PRINCIPAL_INVESTIGATOR
Medical University of Graz
Holger Flick, MD
Role: PRINCIPAL_INVESTIGATOR
Medical University Hospital Graz
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University Hospital of Graz
Graz, Styria, Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23-049
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.